Lv5
1458 积分 2023-08-09 加入
Immunohistochemistry in gynecologic carcinomas: Practical update with diagnostic and clinical considerations based on the 2020 WHO classification of tumors
1天前
待确认
Visual-Language Foundation Models in Medical Imaging: A Systematic Review and Meta-Analysis of Diagnostic and Analytical Applications
1个月前
已关闭
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
2个月前
已完结
Concerns regarding the AtTEnd trial in advanced endometrial carcinoma
2个月前
已完结
PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
2个月前
已完结
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
2个月前
已完结
373O First-line iparomlimab and tuvonralimab (QL1706) + chemotherapy (chemo) ± bevacizumab (BEV) for recurrent or metastatic cervical cancer (r/mCC): Updated results of the phase II DUBHE-C-204 study
5个月前
已完结
PD‐1 and PD‐L1 upregulation promotes CD8+ T‐cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients
6个月前
已完结
Non-Small Cell Lung Cancer: Histopathologic Correlates for Texture Parameters at CT
7个月前
已完结
皖公网安备34019202002308
